A Clinical Trial to Evaluate Safety of Gusacitinib in Patients With Systemic Lupus Erythematosus (SLE) or Lupus
Condition(s):Systemic Lupus ErythematosusLast Updated:March 25, 2024Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):Systemic Lupus ErythematosusLast Updated:March 25, 2024Not yet recruiting
Condition(s):Systemic Lupus ErythematosusLast Updated:January 27, 2020Completed
Condition(s):Systemic Lupus ErythematosusLast Updated:June 14, 2022Not yet recruiting
Condition(s):Systemic Lupus Erythematosus (SLE)Last Updated:July 21, 2023Completed
Condition(s):SLELast Updated:June 28, 2019Unknown status
Condition(s):Systemic Lupus ErythematosusLast Updated:March 12, 2024Recruiting
Condition(s):System Lupus ErythematosusLast Updated:December 14, 2021Unknown status
Condition(s):Systemic Lupus Erythematosus; Rheumatoid Arthritis; BLyS PolymorphismLast Updated:December 21, 2022Recruiting
Condition(s):Systemic Lupus ErythematosusLast Updated:September 16, 2013Completed
Condition(s):Juvenile Systemic Lupus ErythematosusLast Updated:August 20, 2021Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.